Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 29;12(9):1339.
doi: 10.3390/life12091339.

UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma

Affiliations
Review

UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma

Alba Loras et al. Life (Basel). .

Abstract

Introduction: Due to its aggressiveness, cutaneous melanoma (CM) is responsible for most skin cancer-related deaths worldwide. The origin of CM is closely linked to the appearance of UV-induced somatic mutations in melanocytes present in normal skin or in CM precursor lesions (nevi or dysplastic nevi). In recent years, new NGS studies performed on CM tissue have increased the understanding of the genetic somatic changes underlying melanomagenesis and CM tumor progression.

Methods: We reviewed the literature using all important scientific databases. All articles related to genomic mutations in CM as well as normal skin and nevi were included, in particular those related to somatic mutations produced by UV radiation.

Conclusions: CM development and progression are strongly associated with exposure to UV radiation, although each melanoma subtype has different characteristic genetic alterations and evolutionary trajectories. While BRAF and NRAS mutations are common in the early stages of tumor development for most CM subtypes, changes in CDKN2A, TP53 and PTEN, together with TERT promoter mutations, are especially common in advanced stages. Additionally, large genome duplications, loss of heterozygosity, and copy number variations are hallmarks of metastatic disease. Finally, the mutations driving melanoma targeted-therapy drug resistance are also summarized. The complete sequential stages of clonal evolution leading to CM onset from normal skin or nevi are still unknown, so further studies are needed in this field to shed light on the molecular pathways involved in CM malignant transformation and in melanoma acquired drug resistance.

Keywords: UV exposure; clonal evolution; cutaneous melanoma; genomic mutations; mutational signatures; nevus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Driver genes involved in CM development and progression from normal healthy skin and nevus.

Similar articles

Cited by

References

    1. Cherepakhin O.S., Argenyi Z.B., Moshiri A.S. Genomic and Transcriptomic Underpinnings of Melanoma Genesis, Progression, and Metastasis. Cancers. 2021;14:123. doi: 10.3390/cancers14010123. - DOI - PMC - PubMed
    1. Kontogianni G., Piroti G., Maglogiannis I., Chatziioannou A., Papadodima O. Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece. Cancers. 2018;10:96. doi: 10.3390/cancers10040096. - DOI - PMC - PubMed
    1. Bobos M. Histopathologic Classification and Prognostic Factors of Melanoma: A 2021 Update. Ital. J. Dermatol. Venerol. 2021;156:300–321. doi: 10.23736/S2784-8671.21.06958-3. - DOI - PubMed
    1. Hernando B., Dietzen M., Parra G., Gil-Barrachina M., Pitarch G., Mahiques L., Valcuende-Cavero F., McGranahan N., Martinez-Cadenas C. The Effect of Age on the Acquisition and Selection of Cancer Driver Mutations in Sun-Exposed Normal Skin. Ann. Oncol. 2021;32:412–421. doi: 10.1016/j.annonc.2020.11.023. - DOI - PMC - PubMed
    1. Cutts A., Venn O., Dilthey A., Gupta A., Vavoulis D., Dreau H., Middleton M., McVean G., Taylor J.C., Schuh A. Characterisation of the Changing Genomic Landscape of Metastatic Melanoma Using Cell Free DNA. NPJ Genom. Med. 2017;2:25. doi: 10.1038/s41525-017-0030-7. - DOI - PMC - PubMed